At Epigenica, we build innovative products for epigenetic analysis that foster scientific breakthroughs to advance human health.
Enzo Life Sciences
Global Life Sciences Company Serving the Scientific Community for over 50 Years Enzo Life Sciences is a focused global life science company delivering innovative solutions to support biomedical research, translational science, and drug development. For more than 50 years, Enzo has been a leader in product development and technology innovation, serving academic research institutions and biopharma partners worldwide. With a comprehensive portfolio of widely cited and highly trusted quality products—including antibodies, assays, genomic probes, proteins, and biochemicals—Enzo supports a broad range of applications across genomic, protein, cellular, tissue, and small molecule analysis. Proprietary technologies and products play key roles at every stage of translational research and therapeutic development. Enzo Life Sciences’ deep scientific expertise, flexible solutions, and versatile product offerings accelerate research timelines, enabling partners to effectively and efficiently advance discovery and development efforts.
Enamine
Enamine is a global provider of Screening Compounds (small molecules), Building Blocks, Fragments, HTS/AMDE/PK services, and custom synthesis for supporting a wide range of research programs conducted by pharmaceutical and biotech companies, drug discovery centres, academic institutions and other research organizations worldwide. Enamine offers a broad range of targeted libraries covering many of the most important cancer targets. These libraries have been designed using diverse computational approaches and algorithms by Enamine’s CADD team, as well as through collaborations with industry partners and academic groups.
Elabscience Bionovation Inc
Elabscience equips both R & D platform and a manufacturing plant, with in-house QC for every product, to ensure consistent and robust experimental results. Elabscience major products cover ELISA Kits, Proteins, Flow cytometry Antibodies, Cell function kits, and Metabolism kits, which have already been cited in numerous publications.
Dojindo Molecular Technologies, Inc.
With over 80 years of scientific heritage in Japan and more than 30 years of experience in the United States, Dojindo Laboratories and its U.S. subsidiary, Dojindo Molecular Technologies, support life-science research worldwide through innovative chemical tools and high-quality assay technologies. Dojindo Molecular Technologies specializes in the development and supply of unique fluorescence probes, cell-based assay kits, and biochemical reagents designed to enable precise analysis of cellular metabolism, redox biology, mitochondrial function, lysosomal dynamics, ferroptosis, and other cancer-relevant pathways. Our products are widely used in academic, pharmaceutical, and biotechnology research for both fundamental discovery and drug development.
DIMA Biotechnology LLC
DIMA Biotechnology LLC accelerates cancer research through innovative membrane protein and monoclonal antibody discovery platforms. We specialize in producing full length, hard-to-express targets such as GPCRs, ion channels, and transporters et al. All our proteins are overexpressed in HEK293 cells to ensure high quality expression with correct PTMS. Our proprietary platforms include: – Synthetic Nanodisc, PeptiNanodisc, and Detergent-based systems: providing pure full length transmembrane proteins purified by affinity chromatography. – VLP (Virus Like Particles), MNP (Membrane Nano Particles), and Exosome-based systems—which present proteins in their native context but are not purified proteins. We offer over 500 Nanodisc products, with 300+ available in stock for next day delivery covering many GPCR and channel proteins. In antibody discovery, we provide both single B cell–derived rabbit mAbs and Nanobody development. We offer 5,000+ prevalidated recombinant mAb sequences targeting 500+ cancer relevant proteins, which are ready for out-licensing and testing. Additional IgG candidates can be screened within six weeks using proprietary B cell libraries. Our mammalian cell display platform supports antibody engineering services including humanization, affinity maturation, and functional screening. DIMA delivers integrated solutions from membrane protein production to antibody optimization to advance cancer research and therapeutic development.
Daicel Life Sciences
Daicel Life Sciences provides products for the increasingly complex needs of the Pharmaceutical and related businesses. Included in these capabilities are the following: Daicel’s world-leading Chiral Chromatography products and services, which are routinely used in the development and manufacture of pharmaceutical ingredients. The innovative Actranza® Jet Injection device, used to deliver biologicals, including Nucleic acids, without the use of needles, LNPs or other carriers. Delivery can be SC, ID, or IM. Pharmaceutical Standards for identification and quantification of drug materials. The most recent entry in our Life Sciences portfolio is an Exosome Isolation System which is designed to process up to 5 liters of feed into 20 ml in less than 2 hours. This proprietary system utilizes both chromatography and tangential flow filtration in a fully automated robust process, allowing for easy and efficient isolation of exosomes, with yield and purity rivalling that of any other method. | Daicel Life Sciences provides products and services to a wide array of the Pharmaceutical market. In the area of drug delivery, our Actranza lab. device is designed to inject biological drugs intra-cellularly without the use of carriers, excipients, or vectors of any kind. In animal studies, this unique needle-free injector has been proven to deliver mRNA and DNA into the cell and achieve production of the desired protein or antibody. | Daicel is a diversified technology company with unique capabilities that are being applied to a wide variety of applications, including Medical-grade plastics, Life-saving air bags, Engineered plastics, and the products of our Life Science SBU. Daicel’s Life Sciences SBU provides products for the increasingly complex needs of the Pharmaceutical and related businesses. Included in these capabilities are the following: Daicel’s world-leading Chiral Chromatography products and services, which are routinely used in the development and manufacture of pharmaceutical ingredients. The innovative Actranza® Jet Injection device, used to deliver RNA and DNA vaccines intracellularly without the use of needles, LNPs or other carriers. Pharmaceutical Standards for identification and quantification of drug materials. The most recent entry in our Life Sciences portfolio is an Exosome Isolation System which is designed to process up to 5 liters of feed into 20 ml in less than 2 hours. This proprietary system utilizes both chromatography and tangential flow filtration in a fully automated robust process, allowing for easy and efficient isolation of exosomes, with yield and purity rivalling that of any other method.
Cureline, Inc.
Cureline Group is a global precision and translational medicine CRO providing preclinical and laboratory services to the biopharmaceutical industry since 2003. Cureline Group offers a full range of ISO-certified, CAP-compliant clinical research services (Biobanking, Histo/Digital and molecular pathology, small animal and POC validation) for biopharma researchers conducting preclinical and biomarker / companion diagnostics development projects. Cureline headquarters, based in California (USA), oversees global clinical operations and regulatory affairs in 20+ countries (US, EU, Eastern Europe, China, India, and South America). A preclinical studies center is in Vilnius, Lithuania. With our extensive experience, Cureline has successfully aided more than 850 clients globally. We offer top-notch support for preclinical, therapeutic, and diagnostic clinical trials, as well as implement complex research protocols for precision medicine programs. Our expertise extends to conducting molecular and cellular analyses and providing translational histology/pathology services. Visit www.CurelineGroup.com to learn more.
Creative Biomart Inc
Creative BioMart is a leading biotech company that provides innovative products and services to the scientific community worldwide. We specialize in developing and manufacturing high-quality recombinant proteins, and custom services for life science research, drug discovery, and diagnostic applications. We pride ourselves on our customer-centric approach, which ensures our customers receive exceptional service and support at every stage of their research project. Whether you need any help, our team is always available to help.
China Anti-Cancer Association
China Anti-Cancer Association (CACA) is a non-governmental and non-profit organization in the field of oncology in China. Founded in 1984, it has developed into the largest organization in cancer field with long history and great influence in China. Up to now, CACA has established local anti-cancer associations in all 31 provinces, cities, and autonomous regions across China, creating a network of 200 professional societies. With 162 organization members and over 800,000 individual members, CACA serves as a significant platform for academic exchanges, public education, promoting CACA Guidelines, and international cooperation in the field of oncology.